INTERNATIONAL PATENT: ENGIMMUNE THERAPEUTICS AG FILES APPLICATION FOR "PROTEINS COMPRISING T CELL RECEPTOR CONSTANT DOMAINS"

GENEVA, Nov. 3 -- ENGIMMUNE THERAPEUTICS AG (c/o Switzerland Innovation Park Basel Area AGHegenheimermattweg 167A4123 Allschwil) filed a patent application (PCT/EP2025/060894) for "PROTEINS COMPRISING T CELL RECEPTOR CONSTANT DOMAINS" on Apr 22, 2025. With publication no. WO/2025/224084, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TAFT, Joseph Michael (c/o Engimmune Therapeutics AGc/o Switzerland Innovation Park Basel Area AGHegenheimermattweg 167A4123 Allschwil), JUNET, Valentin Pierre (c/o Engimmune Therapeutics AGc...